Therapeutic immunotoxins for lymphoid malignancies: the end of the beginning
Leuk Lymphoma
.
2007 Jun;48(6):1067-9.
doi: 10.1080/10428190701344949.
Authors
John C Morris
1
,
John E Janik
Affiliation
1
Clinical Trials, Metabolism Branch, Center for Cancer Research, National Cancer Institute, Mark O. Hatfield Clinical Research Center, Bethesda, MD 20892, USA.
[email protected]
PMID:
17577767
DOI:
10.1080/10428190701344949
No abstract available
Publication types
Comment
MeSH terms
Animals
Clinical Trials, Phase I as Topic / trends
Drug Evaluation, Preclinical
Humans
Immunotoxins / therapeutic use*
Lymphoproliferative Disorders / drug therapy*
Substances
Immunotoxins